Szisztémás szklerózis (szkleroderma): vizsgálatok itt: Belgium
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleRollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
- Where
- Ghent, Leuven
- Életkor
- 5 év to 80 év
- People
- 1072 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07691970 - 3. fázisNot yet taking people in BelgiumRollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.
- Where
- Gent
- People
- 340 worldwide
- Run by
- AstraZeneca AB
See details and how to join2026-526419-13-00 · EU 2026-526419-13-00 - 3. fázisTaking peopleA Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Where
- Anderlecht, Gent, Jette, Leuven, Liège, Yvoir
- Életkor
- 18 év and over
- People
- 448 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07497087 · EU 2025-523884-39-00 - 1. fázisNot yet taking people in BelgiumA Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
- Where
- Leuven
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07873931 - 3. fázisNot yet taking people in BelgiumA Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
- Where
- Leuven, Liège
- Életkor
- 16 év and over
- People
- 92 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07335562 · EU 2025-524337-11-00 - 2/3. fázisTaking peopleA Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- Where
- Gent, Liège
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05878717 · EU 2023-503219-14-01 - 2. fázisTaking peoplePlatform Clinical Study for Conquering Scleroderma
- Where
- Gent, Liège
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Scleroderma Research Foundation, Inc.
See details and how to joinNCT06195072 · EU 2023-507129-40-00 - No phaseTaking peopleMedical Follow-up of New Cases of Polyarthritis in Children and Young Adults
- Where
- Brussels
- Életkor
- 2 év to 50 év
- People
- 1000
- Run by
- Université Catholique de Louvain
See details and how to joinNCT07000916